Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126448131 | 12644813 | 1 | I | 2015 | 20160808 | 20160811 | 20160811 | PER | US-PFIZER INC-2016379894 | PFIZER | 62.00 | YR | F | Y | 81.65000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126448131 | 12644813 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 35 MG, 3X/DAY | U | 20699 | 35 | MG | PROLONGED-RELEASE CAPSULE | TID | |||||
| 126448131 | 12644813 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, 1X/DAY IN THE MORNING | U | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 126448131 | 12644813 | 3 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 35 MG 2 CAPSULES ONCE | U | 20699 | 70 | MG | PROLONGED-RELEASE CAPSULE | ||||||
| 126448131 | 12644813 | 4 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 10 MG, 1X/DAY IN THE EVENING | 0 | 10 | MG | QD | |||||||
| 126448131 | 12644813 | 5 | C | EXEMESTANE. | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY IN THE MORNING | 0 | 25 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126448131 | 12644813 | 1 | Depression |
| 126448131 | 12644813 | 4 | Asthma |
| 126448131 | 12644813 | 5 | Hormone therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126448131 | 12644813 | Balance disorder | |
| 126448131 | 12644813 | Dizziness | |
| 126448131 | 12644813 | Nausea | |
| 126448131 | 12644813 | Peripheral coldness | |
| 126448131 | 12644813 | Poor quality sleep | |
| 126448131 | 12644813 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126448131 | 12644813 | 1 | 2015 | 201512 | 0 | |
| 126448131 | 12644813 | 2 | 2015 | 20160722 | 0 | |
| 126448131 | 12644813 | 3 | 20160801 | 0 | ||
| 126448131 | 12644813 | 5 | 201405 | 0 |